Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

First independent validation of the proton-boron capture therapy concept

A. Jelínek Michaelidesová, P. Kundrát, O. Zahradníček, I. Danilová, K. Pachnerová Brabcová, J. Vachelová, J. Vilimovský, M. David, V. Vondráček, M. Davídková

. 2024 ; 14 (1) : 19264. [pub] 20240820

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019301

Grantová podpora
21-06451S Czech Science Foundation

Boron has been suggested to enhance the biological effectiveness of proton beams in the Bragg peak region via the p + 11B → 3α nuclear capture reaction. However, a number of groups have observed no such enhancement in vitro or questioned its proposed mechanism recently. To help elucidate this phenomenon, we irradiated DU145 prostate cancer or U-87 MG glioblastoma cells by clinical 190 MeV proton beams in plateau or Bragg peak regions with or without 10B or 11B isotopes added as sodium mercaptododecaborate (BSH). The results demonstrate that 11B but not 10B or other components of the BSH molecule enhance cell killing by proton beams. The enhancement occurs selectively in the Bragg peak region, is present for boron concentrations as low as 40 ppm, and is not due to secondary neutrons. The enhancement is likely initiated by proton-boron capture reactions producing three alpha particles, which are rare events occurring in a few cells only, and their effects are amplified by intercellular communication to a population-level response. The observed up to 2-3-fold reductions in survival levels upon the presence of boron for the studied prostate cancer or glioblastoma cells suggest promising clinical applications for these tumour types.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019301
003      
CZ-PrNML
005      
20241024111517.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-024-69370-y $2 doi
035    __
$a (PubMed)39164312
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Jelínek Michaelidesová, Anna $u Nuclear Physics Institute of the Czech Academy of Sciences, Husinec - Řež 130, 250 68, Řež, Czech Republic $u Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Břehová 78/7, 115 19, Prague, Czech Republic
245    10
$a First independent validation of the proton-boron capture therapy concept / $c A. Jelínek Michaelidesová, P. Kundrát, O. Zahradníček, I. Danilová, K. Pachnerová Brabcová, J. Vachelová, J. Vilimovský, M. David, V. Vondráček, M. Davídková
520    9_
$a Boron has been suggested to enhance the biological effectiveness of proton beams in the Bragg peak region via the p + 11B → 3α nuclear capture reaction. However, a number of groups have observed no such enhancement in vitro or questioned its proposed mechanism recently. To help elucidate this phenomenon, we irradiated DU145 prostate cancer or U-87 MG glioblastoma cells by clinical 190 MeV proton beams in plateau or Bragg peak regions with or without 10B or 11B isotopes added as sodium mercaptododecaborate (BSH). The results demonstrate that 11B but not 10B or other components of the BSH molecule enhance cell killing by proton beams. The enhancement occurs selectively in the Bragg peak region, is present for boron concentrations as low as 40 ppm, and is not due to secondary neutrons. The enhancement is likely initiated by proton-boron capture reactions producing three alpha particles, which are rare events occurring in a few cells only, and their effects are amplified by intercellular communication to a population-level response. The observed up to 2-3-fold reductions in survival levels upon the presence of boron for the studied prostate cancer or glioblastoma cells suggest promising clinical applications for these tumour types.
650    _2
$a lidé $7 D006801
650    12
$a terapie metodou neutronového záchytu (bor-10) $x metody $7 D016754
650    12
$a protonová terapie $x metody $7 D061766
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a nádory prostaty $x radioterapie $x farmakoterapie $7 D011471
650    _2
$a glioblastom $x radioterapie $x farmakoterapie $7 D005909
650    _2
$a bor $x chemie $7 D001895
650    _2
$a viabilita buněk $x účinky léků $x účinky záření $7 D002470
650    _2
$a protony $7 D011522
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kundrát, Pavel $u Nuclear Physics Institute of the Czech Academy of Sciences, Husinec - Řež 130, 250 68, Řež, Czech Republic
700    1_
$a Zahradníček, Oldřich $u Nuclear Physics Institute of the Czech Academy of Sciences, Husinec - Řež 130, 250 68, Řež, Czech Republic
700    1_
$a Danilová, Irina $u Nuclear Physics Institute of the Czech Academy of Sciences, Husinec - Řež 130, 250 68, Řež, Czech Republic $u Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Břehová 78/7, 115 19, Prague, Czech Republic
700    1_
$a Pachnerová Brabcová, Kateřina $u Nuclear Physics Institute of the Czech Academy of Sciences, Husinec - Řež 130, 250 68, Řež, Czech Republic
700    1_
$a Vachelová, Jana $u Nuclear Physics Institute of the Czech Academy of Sciences, Husinec - Řež 130, 250 68, Řež, Czech Republic
700    1_
$a Vilimovský, Jan $u Proton Therapy Center Czech, Prague, Budínova 2437/1a, 180 00, Prague, Czech Republic
700    1_
$a David, Miroslav $u Thomayer University Hospital, Vídeňská 800, 140 59, Prague, Czech Republic
700    1_
$a Vondráček, Vladimír $u Proton Therapy Center Czech, Prague, Budínova 2437/1a, 180 00, Prague, Czech Republic $u Thomayer University Hospital, Vídeňská 800, 140 59, Prague, Czech Republic
700    1_
$a Davídková, Marie $u Nuclear Physics Institute of the Czech Academy of Sciences, Husinec - Řež 130, 250 68, Řež, Czech Republic. davidkova@ujf.cas.cz
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 14, č. 1 (2024), s. 19264
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39164312 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111511 $b ABA008
999    __
$a ok $b bmc $g 2201874 $s 1231274
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 14 $c 1 $d 19264 $e 20240820 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
GRA    __
$a 21-06451S $p Czech Science Foundation
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...